Epoch Biodesign
Uses AI-designed enzymes to break down plastic and textile waste into recycled nylon polymers.
epochbiodesign.com ↗Why it's here
Raised an oversubscribed $18.3M Series A led by Extantia with Lowercarbon and Inditex, and has since acquired a 52,000 tonne per year nylon 6,6 production site.
source: epochbiodesign.com- Focus
- Enzymatic Recycling
- Founded
- 2019
- Total raised
- $34Msource: techcrunch.com
- Latest round
- Series A, $18.3M, Mar 2025
- Team size
- 11-50 people
- Staff (Companies House accounts)
- 27, average over the period to 31 Mar 2025source: find-and-update.company-information.service.gov.uk
- London office
- 10 Finsbury Square, Islington EC2A 1AJsource: epochbiodesign.com
- London presence
- HQsource: webpronews.com
- Investors
- Extantia (lead), Day One Ventures, Happiness Capital, Inditex, Kibo Invest, Lowercarbon Capitalsource: techcrunch.com
- Nearest station
- Moorgate, 332 m
- Visas
- Licensed visa sponsor, listed as Epoch Biodesign Ltd.source: gov.uk
- Elsewhere
- LinkedIn ↗
Verified 3 Oct 2026. How we verify · Suggest a fix